 ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited product sales results for the first quarter ended March 31, 2020. Total product sales increased by approximately 11.3, or 500,000, to approximately 4.9 million during the quarter ended March 31, 2020 versus last years first quarter, which ended March 31, 2019. Total product sales increased by approximately 13.6, or 1.7 million, to approximately 14.2 million during the trailing twelve-month period ended March 31, 2020 versus the trailing twelve-month period ended March 31, 2019. 